Data / Form D filings / Candid Therapeutics, Inc.
Candid Therapeutics, Inc.: Form D filing
Candid Therapeutics, Inc., a health care company in San Diego, CA, filed a Form D with the SEC in 2024. The latest, on September 13, 2024, reports $206.2 million sold of a $206.2 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11622 EL CAMINO REAL, SUITE 150, San Diego, CA, 92130
- Phone
- (858) 247-0550
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2035778
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | New notice | $206,203,454 | $206,203,454 | 33 | Aug 19, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Tong, Ph.D. | Director | |
| Arvind Kush | Executive Officer | |
| Timothy Lu, M.D. | Executive Officer | |
| Kenneth Song, M.D. | Executive Officer, Director | |
| Aaron Royston, M.D. | Director | |
| Bernie Huyghe, Ph.D. | Executive Officer | |
| Michael Rome, M.D. | Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Sep 9, 2024 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Candid Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.